Cargando…
Stop, Listen, and Learn: Using Mixed Methods to Add Value to Clinical Trials*
This commentary discusses the concept of value-based or value-focused health care as a rationale for researchers to incorporate mixed methods study designs a priori into clinical trials evaluating traditional, complementary, alternative, and integrative medicine (TCAIM). Along with assessing patient...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591665/ https://www.ncbi.nlm.nih.gov/pubmed/31232083 http://dx.doi.org/10.1177/2515690X19857073 |
_version_ | 1783429766717636608 |
---|---|
author | Hunter, Jennifer Armour, Mike |
author_facet | Hunter, Jennifer Armour, Mike |
author_sort | Hunter, Jennifer |
collection | PubMed |
description | This commentary discusses the concept of value-based or value-focused health care as a rationale for researchers to incorporate mixed methods study designs a priori into clinical trials evaluating traditional, complementary, alternative, and integrative medicine (TCAIM). Along with assessing patient outcomes, information about patients’ experiences and preferences are needed to determine the value of an intervention. Incorporating a mixed-methods approach can improve the quality of clinical trials and provide important information about the potential value of the intervention. |
format | Online Article Text |
id | pubmed-6591665 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-65916652019-06-28 Stop, Listen, and Learn: Using Mixed Methods to Add Value to Clinical Trials* Hunter, Jennifer Armour, Mike J Evid Based Integr Med Commentary: Invitation This commentary discusses the concept of value-based or value-focused health care as a rationale for researchers to incorporate mixed methods study designs a priori into clinical trials evaluating traditional, complementary, alternative, and integrative medicine (TCAIM). Along with assessing patient outcomes, information about patients’ experiences and preferences are needed to determine the value of an intervention. Incorporating a mixed-methods approach can improve the quality of clinical trials and provide important information about the potential value of the intervention. SAGE Publications 2019-06-23 /pmc/articles/PMC6591665/ /pubmed/31232083 http://dx.doi.org/10.1177/2515690X19857073 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Commentary: Invitation Hunter, Jennifer Armour, Mike Stop, Listen, and Learn: Using Mixed Methods to Add Value to Clinical Trials* |
title | Stop, Listen, and Learn: Using Mixed Methods to Add Value to Clinical
Trials* |
title_full | Stop, Listen, and Learn: Using Mixed Methods to Add Value to Clinical
Trials* |
title_fullStr | Stop, Listen, and Learn: Using Mixed Methods to Add Value to Clinical
Trials* |
title_full_unstemmed | Stop, Listen, and Learn: Using Mixed Methods to Add Value to Clinical
Trials* |
title_short | Stop, Listen, and Learn: Using Mixed Methods to Add Value to Clinical
Trials* |
title_sort | stop, listen, and learn: using mixed methods to add value to clinical
trials* |
topic | Commentary: Invitation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591665/ https://www.ncbi.nlm.nih.gov/pubmed/31232083 http://dx.doi.org/10.1177/2515690X19857073 |
work_keys_str_mv | AT hunterjennifer stoplistenandlearnusingmixedmethodstoaddvaluetoclinicaltrials AT armourmike stoplistenandlearnusingmixedmethodstoaddvaluetoclinicaltrials |